Management of imported malaria in Europe

Autor: Askling, Hh, Bruneel, F, Burchard, G, Castelli, Francesco, Chiodini, Pl, Grobusch, Mp, Lopez Vélez, R, Paul, M, Petersen, E, Popescu, C, Ramharter, M, Schlagenhauf, P, European Society for Clinical Microbiology, Infectious Diseases Study Group on Clinical Parasitology

Publikováno v: Malaria Journal, Vol 11, Iss 1, p 328 (2012)
Malaria Journal
Askling, H H, Bruneel, F, Burchard, G, Castelli, F, Chiodini, P L, Grobusch, M P, Lopez-Vélez, R, Paul, M, Petersen, E, Popescu, C, Ramharter, M, Schlagenhauf, P & European Society for Clinical Microbiology and Infectious Diseases Study Group on Clinical Parasitology 2012, ' Management of imported malaria in Europe ', Malaria Journal, vol. 11, pp. 328 . https://doi.org/10.1186/1475-2875-11-328

In this position paper, the European Society for Clinical Microbiology and Infectious Diseases, Study Group on Clinical Parasitology, summarizes main issues regarding the management of imported malaria cases. Malaria is a rare diagnosis in Europe, bu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e260cc6880461f66bcf781abdc1aaec
http://www.malariajournal.com/content/11/1/328

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trial.

Autor: Jastorff A; Janssen Vaccines & Prevention B.V., Archimedesweg 4, 2333, CN, Leiden, The Netherlands., Gymnopoulou E; Janssen Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium. Electronic address: egymnopo@its.jnj.com., Salas J; IQVIA RDS GmbH, Unterschweinstiege 2-14, 60549 Frankfurt am Main, Germany., Merrall E; Janssen Vaccines & Prevention B.V., Archimedesweg 4, 2333, CN, Leiden, The Netherlands. Electronic address: emerrall@its.jnj.com., Buntinx E; Animal Research Center, Alkerstraat 28-30-30A-32Z 3570 Alken, Belgium. Electronic address: erik.buntinx@anima-alken.be., Martin C; C.H.U. St Pierre Maladies Infectieuses, rue Haute 322, Brussels, Belgium. Electronic address: charlotte.martin@stpierre-bru.be., Askling HH; Academic Specialist Centre, Stockholm Health Care Services, Solnavägen 1E 113 65 Stockholm, and Department of Medicine/Solna, Karolinska Institutet, Nobels väg 5, Solna, 171 77 Stockholm, Sweden. Electronic address: helena.hervius.askling@ki.se., Schenkenberger I; Velocity Clinical Research GmbH Standort Berlin, Ansbacher St. 17-19, Berlin 10787, Germany. Electronic address: ischenkenberger@velocityclinical.com., Yuste AC; Clinical Unit of Infectious Diseases, Reina Sofia University Hospital-IMIBIC/CIBERINFEC. Ave. Menendez Pidal s/n, Cordoba 14004, Spain. Electronic address: angela.cano.sspa@juntadeandalucia.es., Smith W; Volunteer Research Group and New Orleans Center for Clinical Research, 1924 Alcoa Hwy, Knoxville, TN 37920, United States. Electronic address: William.Smith@amrllc.com., Sotolongo R; Research Institute of South Florida Inc. 9835 SW 72 St Suite 201, Miami, FL 33173, United States. Electronic address: rsotolongo@miamimedtrials.com., Von Engelhardt C; Klinische Forschung Schwerin GmbH, Friedrichstrasse 1, Schwerin 19055, Germany. Electronic address: charlotte.engelhardt@pratia.com., Bastian AR; Janssen Vaccines & Prevention B.V., Archimedesweg 4, 2333, CN, Leiden, The Netherlands., Comeaux C; Janssen Vaccines & Prevention B.V., Archimedesweg 4, 2333, CN, Leiden, The Netherlands., Ligtenberg N; Janssen Vaccines & Prevention B.V., Archimedesweg 4, 2333, CN, Leiden, The Netherlands. Electronic address: nynke@ligtenberg-online.com., Callendret B; Janssen Vaccines & Prevention B.V., Archimedesweg 4, 2333, CN, Leiden, The Netherlands., Heijnen E; Janssen Vaccines & Prevention B.V., Archimedesweg 4, 2333, CN, Leiden, The Netherlands.

Publikováno v: Vaccine [Vaccine] 2024 Nov 12; Vol. 43 (Pt 1), pp. 126514. Date of Electronic Publication: 2024 Nov 12.

Streamlining malaria prevention recommendations for travellers: current and future approaches.

Autor: McGuinness SL; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Infectious Diseases, The Alfred Hospital, Melbourne, Australia., Veit O; Center for Tropical and Travel Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.; Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland., Angelin M; Department of Clinical Microbiology, Infectious Diseases, Umeå University, Umeå, Sweden., Antonini P; Division of Infectious Diseases, Ente Ospedaliero Cantonale Lugano, Lugano, Switzerland., Boecken G; Health Services, Federal Foreign Office, Regional Medical Office for South America, Buenos Aires, Argentina., Boering M; Dutch Coordination Centre for Travellers Health Advice., Bühler S; Division of Hygiene and Infectious Diseases, Institute for Hygiene and Environment, Hamburg, Germany., Calleri G; Infectious and Tropical Diseases Unit, Amedeo di Savoia Hospital, Turin, Italy., Éperon G; Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland.; Faculty of Medicine, University of Geneva, Geneva, Switzerland., Flaherty G; School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland., Gossner C; European Centre for Disease Prevention and Control, Stockholm, Sweden., Askling HH; Academic Specialist Centre, Stockholm Health Services, Region Stockholm, Sweden.; Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden., Holmberg V; Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Kuenzli E; Center for Tropical and Travel Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Landry P; Private Practice, Neuchâtel, Switzerland., Lefevre E; Dutch Coordination Centre for Travellers Health Advice., Libman M; J.D. MacLean Centre for Tropical Medicine, McGill University, Montreal Canada., Longley N; Hospital for Tropical Diseases, University College London Hospitals, London, United Kingdom.; London School of Hygiene and Tropical Medicine, London., Maniewski-Kelner U; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Neumayr A; Center for Tropical and Travel Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Rapp C; Department of Infectious and Tropical Diseases, American Hospital of Paris, Neuilly, France., Ridpath AD; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Rodriguez N; ISGlobal-Hospital Clinic Barcelona, Universitat de Barcelona, Barcelona, Spain., Rosdahl A; School of Medical Sciences, Orebro University, Orebro, Sweden.; Department of Infectious Disease, Orebro University Hospital, Orebro, Sweden., Rosenbusch D; Health Services, Federal Foreign Office, Berlin, Germany., Rossanese A; Department of Infectious-Tropical Diseases and Microbiology, IRCCS 'Sacro Cuore-Don Calabria', Negrar di Valpolicella, Verona, Italy., Rothe C; Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich., Schlagenhauf P; WHO Collaborating Centre for Travellers' Health, Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Switzerland., Soentjens P; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Staehelin C; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Visser J; Department Primary Health Care & General Practice, University of Otago, New Zealand., Visser L; Dutch Coordination Centre for Travellers Health Advice.; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands., Wagner A; Center of Pathophysiology, Infectiology and Immunology, Institute of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Vienna, Austria., Walker A; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Wiedermann U; Center of Pathophysiology, Infectiology and Immunology, Institute of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Vienna, Austria., Wroczynska A; Polish Institute of Evidence Based Medicine, Krakow, Poland., Hatz C; Center for Tropical and Travel Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.

Publikováno v: Journal of travel medicine [J Travel Med] 2024 Aug 21. Date of Electronic Publication: 2024 Aug 21.

Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey Study.

Autor: Themistocleous S; School of Medicine, European University Cyprus, Nicosia, Cyprus., Argyropoulos CD; School of Medicine, European University Cyprus, Nicosia, Cyprus., Vogazianos P; Department of Behavioural and Social Sciences, School of Humanities, Social and Education Sciences, European University Cyprus, Nicosia, Cyprus., Shiamakkides G; School of Medicine, European University Cyprus, Nicosia, Cyprus., Noula E; School of Medicine, European University Cyprus, Nicosia, Cyprus., Nearchou A; School of Medicine, European University Cyprus, Nicosia, Cyprus., Yiallouris A; School of Medicine, European University Cyprus, Nicosia, Cyprus., Filippou C; School of Medicine, European University Cyprus, Nicosia, Cyprus., Stewart FA; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.; Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany., Koniordou M; Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece., Kopsidas I; Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece., Askling HH; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.; Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden., Vene S; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.; Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden., Gagneux-Brunon A; Centre d'investigation clinique-INSERM 1408, University Hospital of Saint-Etienne, Saint-Etienne, France.; Groupe Immunité Muqueuse et Agents Pathogènes (GIMAP), EA3064 - Medical School of Saint-Etienne, University of Lyon, Saint-Etienne, France., Prellezo JB; Microbiology Section, Department of Pharmaceutical Sciences and of Health, Faculty of Pharmacy, Universidad San Pablo-Centro de Estudios Universitarios (CEU), Madrid, Spain., Álvarez-Barco E; Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland., Salmanton-García J; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.; Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany., Leckler J; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.; Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany., Macken AJ; Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland., Davis RJ; Department of Diagnostic and Public Health, Infectious Diseases, University of Verona, Verona, Italy., Azzini AM; Department of Diagnostic and Public Health, Infectious Diseases, University of Verona, Verona, Italy., Armeftis C; School of Medicine, European University Cyprus, Nicosia, Cyprus., Hellemans M; Vaccine & Infectious Disease Institute - VAXINFECTIO, Centre of Evaluation of Vaccination,, Faculty of Medicine and Health Science, Universiteit Antwerpen, Antwerp, Belgium., Di Marzo R; European Vaccine Initiative (EVI), Heidelberg, Germany., Luis C; European Vaccine Initiative (EVI), Heidelberg, Germany., Olesen OF; European Vaccine Initiative (EVI), Heidelberg, Germany., Valdenmaiier O; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Jakobsen SF; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Nauclér P; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.; Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden., Launay O; Inserm CIC 1417, I-REIVAC, University Hospital of Cochin-Broca-Hôtel-Dieu, University of Paris-Descartes, Paris, France., Mallon P; Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland., Ochando J; Microbiology Section, Department of Pharmaceutical Sciences and of Health, Faculty of Pharmacy, Universidad San Pablo-Centro de Estudios Universitarios (CEU), Madrid, Spain., van Damme P; Vaccine & Infectious Disease Institute - VAXINFECTIO, Centre of Evaluation of Vaccination,, Faculty of Medicine and Health Science, Universiteit Antwerpen, Antwerp, Belgium., Tacconelli E; Department of Diagnostic and Public Health, Infectious Diseases, University of Verona, Verona, Italy., Zaoutis T; Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece., Cornely OA; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.; Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.; Faculty of Medicine, and University Hospital Cologne, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Pana ZD; School of Medicine, European University Cyprus, Nicosia, Cyprus.

Publikováno v: JMIR public health and surveillance [JMIR Public Health Surveill] 2024 Apr 04; Vol. 10, pp. e47241. Date of Electronic Publication: 2024 Apr 04.